PHARMAGEN, INC. Deferred Tax Assets, Net of Valuation Allowance
PHARMAGEN, INC. had Deferred Tax Assets, Net of Valuation Allowance of $405.97 thousand as of 2012-06-30, per its 10-Q/A filed 2012-09-14.
Discontinued › Notes › Income Taxes › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsNet · last filed 2012-09-14
- 2012-06-30: Deferred Tax Assets, Net of Valuation Allowance $405.97K.
- 2011-12-31: Deferred Tax Assets, Net of Valuation Allowance $128.05K.
| Period end | Deferred Tax Assets, Net of Valuation Allowance |
|---|---|
| 2012-06-30 | $405.97K 10-Q/A · filed 2012-09-14 |
| 2011-12-31 | $128.05K 10-Q/A · filed 2012-09-14 |